BIOMAT Database Logo BIOMAT Database Logo

Zidovudine overdose in an asymptomatic HIV seropositive patient with hemophilia. 1992

R A Stern, and C M van der Horst, and S R Hooper, and K M Bloodgood, and K A High
Department of Psychiatry, University of North Carolina, Chapel Hill School of Medicine 27599-7160.

UI MeSH Term Description Entries
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001774 Blood Chemical Analysis An examination of chemicals in the blood. Analysis, Blood Chemical,Chemical Analysis, Blood,Analyses, Blood Chemical,Blood Chemical Analyses,Chemical Analyses, Blood
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D062787 Drug Overdose Accidental or deliberate use of a medication or street drug in excess of normal dosage. Drug Overdoses,Overdose, Drug,Overdoses, Drug

Related Publications

R A Stern, and C M van der Horst, and S R Hooper, and K M Bloodgood, and K A High
Poor tolerance of zidovudine in an HIV-asymptomatic patient with alpha-thalassemia.
July 1991, The American journal of medicine,
R A Stern, and C M van der Horst, and S R Hooper, and K M Bloodgood, and K A High
[An HIV-seropositive patient with fever].
January 1990, Nederlands tijdschrift voor geneeskunde,
R A Stern, and C M van der Horst, and S R Hooper, and K M Bloodgood, and K A High
Erratic zidovudine bioavailability in HIV seropositive patients.
March 1993, The Journal of antimicrobial chemotherapy,
R A Stern, and C M van der Horst, and S R Hooper, and K M Bloodgood, and K A High
Zidovudine in asymptomatic HIV infection.
September 1990, The New England journal of medicine,
R A Stern, and C M van der Horst, and S R Hooper, and K M Bloodgood, and K A High
Zidovudine in asymptomatic HIV infection.
December 1993, The New England journal of medicine,
R A Stern, and C M van der Horst, and S R Hooper, and K M Bloodgood, and K A High
Zidovudine in asymptomatic HIV infection.
December 1993, The New England journal of medicine,
R A Stern, and C M van der Horst, and S R Hooper, and K M Bloodgood, and K A High
Zidovudine in asymptomatic HIV infection.
December 1993, The New England journal of medicine,
R A Stern, and C M van der Horst, and S R Hooper, and K M Bloodgood, and K A High
[Zidovudine in asymptomatic HIV infection].
August 1991, Medizinische Monatsschrift fur Pharmazeuten,
R A Stern, and C M van der Horst, and S R Hooper, and K M Bloodgood, and K A High
Neuropathological changes in an asymptomatic HIV seropositive man.
February 1988, Annals of neurology,
R A Stern, and C M van der Horst, and S R Hooper, and K M Bloodgood, and K A High
HIV-seropositive thrombocytopenia: the action of zidovudine.
November 1991, AIDS (London, England),
Copied contents to your clipboard!